|
Volume
1 Number 3
March 2013
|
|
Home
>
Disciplines
>
Publications
>
Prostate
Cancer Research
>
Volume
1, Year 2013
>
Number 3, March
|
|
|
CONTENTS
|
▼
|
|
CASE
REPORTS
DIAGNOSIS
FOLLOW-UP,
QUALITY OF LIFE
INTEGRATIVE
MEDICINE
PROGNOSIS
TREATMENT
|
|
|
CASE
REPORTS
|
▲
|
.
|
Pepe P,
Fraggetta F, Tornabene F, Nicolosi M, Aragona F.
Solitary
lung metastasis after radical prostatectomy in presence of
undetectable PSA.
Arch
Ital Urol Androl. 2012 Dec;84(4):208-10.
Source
|
Abstract
|
Similar
articles
|
|
|
DIAGNOSIS
|
▲
|
.
|
Chang
SL, Harshman LC, Presti JC Jr.
Impact
of common medications on serum total prostate-specific antigen
levels: analysis of the National Health and Nutrition Examination
Survey.
J
Clin Oncol. 2010 Sep 1;28(25):3951-7. doi:
10.1200/JCO.2009.27.9406. Epub 2010 Aug 2.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Panebianco
V, Barchetti F, Sciarra A, Musio D, Forte V, Gentile V, Tombolini
V, Catalano C.
Prostate
cancer recurrence after radical prostatectomy: the role of 3-T
diffusion imaging in multi-parametric magnetic resonance imaging.
Eur
Radiol. 2013 Feb 2. DOI https://doi.org/10.1007/s00330-013-2768-3.
[Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Vickers
A, Cronin A, Roobol M, Savage C, Peltola M, Pettersson K, Scardino
PT, Schröder F, Lilja H.
Reducing
unnecessary biopsy during prostate cancer screening using a
four-kallikrein panel: an independent replication.
J
Clin Oncol. 2010 May 20;28(15):2493-8. doi:
10.1200/JCO.2009.24.1968. Epub 2010 Apr 26.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Wachter
S, Tomek S, Kurtaran A, Wachter-Gerstner N, Djavan B, Becherer A,
Mitterhauser M, Dobrozemsky G, Li S, Pötter R, Dudczak R,
Kletter K.
11C-acetate
positron emission tomography imaging and image fusion with
computed tomography and magnetic resonance imaging in patients
with recurrent prostate cancer.
J
Clin Oncol. 2006 Jun 1;24(16):2513-9. DOI:
10.1200/JCO.2005.03.5279. Epub 2006 Apr 24.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Xia J,
Gulati R, Au M, Gore JL, Lin DW, Etzioni R.
Effects
of screening on radical prostatectomy efficacy: the prostate
cancer intervention versus observation trial.
J
Natl Cancer Inst. 2013 Apr 17;105(8):546-50. doi:
10.1093/jnci/djt017. Epub 2013 Feb 14.
Source
| Full
text |
Similar
articles
|
|
|
FOLLOW-UP,
QUALITY OF LIFE
|
▲
|
.
|
Barry
MJ, Gallagher PM, Skinner JS, Fowler FJ Jr.
Adverse
effects of robotic-assisted laparoscopic versus open retropubic
radical prostatectomy among a nationwide random sample of
medicare-age men.
J
Clin Oncol. 2012 Feb 10;30(5):513-8. doi:
10.1200/JCO.2011.36.8621. Epub 2012 Jan 3.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Chen RC,
Clark JA, Talcott JA.
Individualizing
quality-of-life outcomes reporting: how localized prostate cancer
treatments affect patients with different levels of baseline
urinary, bowel, and sexual function.
J
Clin Oncol. 2009 Aug 20;27(24):3916-22. doi:
10.1200/JCO.2008.18.6486. Epub 2009 Jul 20.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Crook
JM, Gomez-Iturriaga A, Wallace K, Ma C, Fung S, Alibhai S, Jewett
M, Fleshner N.
Comparison
of health-related quality of life 5 years after SPIRIT: Surgical
Prostatectomy Versus Interstitial Radiation Intervention Trial.
J
Clin Oncol. 2011 Feb 1;29(4):362-8. doi: 10.1200/JCO.2010.31.7305.
Epub 2010 Dec 13.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Ilic D,
Hindson B, Duchesne G, Millar JL.
A
randomised, double-blind, placebo-controlled trial of nightly
sildenafil citrate to preserve erectile function after radiation
treatment for prostate cancer.
J
Med Imaging Radiat Oncol. 2013 Feb;57(1):81-8. doi:
10.1111/j.1754-9485.2012.02461.x. Epub 2012 Oct 18.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Kimura
M, Bañez LL, Polascik TJ, Bernal RM, Gerber L, Robertson
CN, Donatucci CF, Moul JW.
Sexual
bother and function after radical prostatectomy: predictors of
sexual bother recovery in men despite persistent post-operative
sexual dysfunction.
Andrology.
2013 Mar;1(2):256-61. doi: 10.1111/j.2047-2927.2012.00036.x. Epub
2012 Nov 29.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Pardo Y,
Guedea F, Aguiló F, Fernández P, Macías V,
Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de
León J, Craven-Bratle J, Suárez JF, Boladeras A,
Pont À, Ayala A, Sancho G, Martínez E, Alonso J,
Ferrer M.
Quality-of-life
impact of primary treatments for localized prostate cancer in
patients without hormonal treatment.
J
Clin Oncol. 2010 Nov 1;28(31):4687-96. doi:
10.1200/JCO.2009.25.3245. Epub 2010 Oct 4. Erratum
in: J
Clin Oncol. 2011 Feb 20;29(6):779.
Source
| Full
text |
Erratum
|
Similar
articles
|
|
|
.
|
Resnick
MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS,
Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Van Horn RL,
Penson DF.
Long-term
functional outcomes after treatment for localized prostate cancer.
N
Engl J Med. 2013 Jan 31;368(5):436-45. doi: 10.1056/NEJMoa1209978.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Springer
C, Inferrera A, Pini G, Mohammed N, Fornara P, Greco F.
Laparoscopic
versus open bilateral intrafascial nerve-sparing radical
prostatectomy after TUR-P for incidental prostate cancer: surgical
outcomes and effect on postoperative urinary continence and sexual
potency.
World
J Urol. 2013 Feb 12. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Sullivan
JF, Stember DS, Deveci S, Akin-Olugbade Y, Mulhall JP.
Ejaculation
profiles of men following radiation therapy for prostate cancer.
J
Sex Med. 2013 May;10(5):1410-6. doi: 10.1111/jsm.12101. Epub 2013
Feb 22.
Source
| Full
text |
Similar
articles
|
|
|
INTEGRATIVE
MEDICINE
|
▲
|
.
|
Chao C,
Williams SG, Xu L, Chen J, Wallner LP, Porter KR, Jacobsen SJ.
Statin
therapy is not associated with prostate cancer recurrence among
patients who underwent radiation therapy.
Cancer
Lett. 2013 Feb 15. doi:pii: S0304-3835(13)00129-8.
10.1016/j.canlet.2013.02.017. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
PROGNOSIS
|
▲
|
.
|
Abern
MR, Aronson WJ, Terris MK, Kane CJ, Presti JC Jr, Amling CL,
Freedland SJ.
Delayed
radical prostatectomy for intermediate-risk prostate cancer is
associated with biochemical recurrence: possible implications for
active surveillance from the SEARCH database.
Prostate.
2013 Mar;73(4):409-17. doi: 10.1002/pros.22582. Epub 2012 Sep 19.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Cooperberg
MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H.
Risk
assessment among prostate cancer patients receiving primary
androgen deprivation therapy.
J
Clin Oncol. 2009 Sep 10;27(26):4306-13. doi:
10.1200/JCO.2008.21.5228. Epub 2009 Aug 10.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Eminaga
O, Hinkelammert R, Titze U, Abbas M, Eltze E, Bettendorf O,
Semjonow A.
The
presence of positive surgical margins in patients with
organ-confined prostate cancer results in biochemical recurrence
at a similar rate to that in patients with extracapsular extension
and PSA ≤ 10 ng/ml.
Urol
Oncol. 2014 Jan;32(1):32.e17-25. doi:
10.1016/j.urolonc.2012.11.021. Epub 2013 Feb 19.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Garzotto
M, Beer TM, Hudson RG, Peters L, Hsieh YC, Barrera E, Klein T,
Mori M.
Improved
detection of prostate cancer using classification and regression
tree analysis.
J
Clin Oncol. 2005 Jul 1;23(19):4322-9. Epub 2005 Mar 21. DOI:
10.1200/JCO.2005.11.136
Source
| Full
text |
Similar
articles
|
|
|
.
|
Hashimoto
T, Yoshioka K, Gondo T, Takeuchi H, Nakagami Y, Nakashima J,
Tachibana M.
Predictors
for positive surgical margins after robot-assisted radical
prostatectomy: A single surgeon's series in Japan.
Int
J Urol. 2013 Feb 19. doi: 10.1111/iju.12081. [Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Nam RK,
Toi A, Klotz LH, Trachtenberg J, Jewett MA, Appu S, Loblaw DA,
Sugar L, Narod SA, Kattan MW.
Assessing
individual risk for prostate cancer.
J
Clin Oncol. 2007 Aug 20;25(24):3582-8. DOI:
10.1200/JCO.2007.10.6450
Source
| Full
text |
Similar
articles
|
|
|
.
|
Masuda
H, Fukushima H, Kawakami S, Numao N, Fujii Y, Saito K, Koga F,
Ishioka J, Yokoyama M, Kihara K.
Impact
of advanced age on biochemical recurrence after radical
prostatectomy in Japanese men according to pathological stage.
Jpn
J Clin Oncol. 2013 Apr;43(4):410-6. doi: 10.1093/jjco/hyt017. Epub
2013 Feb 18.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
O'Brien
MF, Cronin AM, Fearn PA, Smith B, Stasi J, Guillonneau B, Scardino
PT, Eastham JA, Vickers AJ, Lilja H.
Pretreatment
prostate-specific antigen (PSA) velocity and doubling time are
associated with outcome but neither improves prediction of outcome
beyond pretreatment PSA alone in patients treated with radical
prostatectomy.
J
Clin Oncol. 2009 Aug 1;27(22):3591-7. doi:
10.1200/JCO.2008.19.9794. Epub 2009 Jun 8.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Shappley
WV 3rd, Kenfield SA, Kasperzyk JL, Qiu W, Stampfer MJ, Sanda MG,
Chan JM.
Prospective
study of determinants and outcomes of deferred treatment or
watchful waiting among men with prostate cancer in a nationwide
cohort.
J
Clin Oncol. 2009 Oct 20;27(30):4980-5. doi:
10.1200/JCO.2008.21.2613. Epub 2009 Aug 31.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Stephenson
AJ, Kattan MW, Eastham JA, Bianco FJ Jr, Yossepowitch O, Vickers
AJ, Klein EA, Wood DP, Scardino PT.
Prostate
cancer-specific mortality after radical prostatectomy for patients
treated in the prostate-specific antigen era.
J
Clin Oncol. 2009 Sep 10;27(26):4300-5. doi:
10.1200/JCO.2008.18.2501. Epub 2009 Jul 27.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Zelefsky
MJ, Eastham JA, Cronin AM, Fuks Z, Zhang Z, Yamada Y, Vickers A,
Scardino PT.
Metastasis
after radical prostatectomy or external beam radiotherapy for
patients with clinically localized prostate cancer: a comparison
of clinical cohorts adjusted for case mix.
J
Clin Oncol. 2010 Mar 20;28(9):1508-13. doi:
10.1200/JCO.2009.22.2265. Epub 2010 Feb 16.
Source
| Full
text |
Similar
articles
|
|
|
TREATMENT
|
▲
|
.
|
Mitsuzuka
K, Koie T, Narita S, Kaiho Y, Yoneyama T, Kawamura S, Tochigi T,
Ohyama C, Habuchi T, Arai Y.
Is
pelvic lymph node dissection required at radical prostatectomy for
low-risk prostate cancer?
Int
J Urol. 2013 Feb 6. doi: 10.1111/iju.12112. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Wilt TJ,
Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei
JT, Gilhooly P, Grob BM, Nsouli I, Iyer P, Cartagena R, Snider G,
Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D,
Wheeler T; Prostate Cancer Intervention versus Observation Trial
(PIVOT) Study Group.
Radical
prostatectomy versus observation for localized prostate cancer.
N
Engl J Med. 2012 Jul 19;367(3):203-13. doi: 10.1056/NEJMoa1113162.
Erratum
in: N
Engl J Med. 2012 Aug 9;367(6):582.
Source
| Full
text |
Erratum
|
Similar
articles
|
|
|
bottom
|
▲
|
|
|